UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2021 » Volume 29, issue 2 (107) » Contemporary views on disorders of neuromiyelitis optica spectrum. Clinical case from personal practice

Contemporary views on disorders of neuromiyelitis optica spectrum. Clinical case from personal practice

Authors

Type of Article

  • Scientific Article

In the Section

  • TO HELP A PRACTICING PHYSICIAN

Key words

Index UDK:
  • 616.831-005.4-036.1:616.155.3

Abstract

Neuromyelitis optica (Devic’s disease) is a demyelinating disease of central nervous system. This disease is progressive and might be fatal.

The authors have analyzed data of domestic and foreign literature on research issue. The idea of modern laboratory and instrumental survey methods was summarized, because clinical manifestation of the disease may be non-specific and differential searching might be extremely wide. The modern schemes of treatment of described syndrome are represented.

As an illustration we used own clinical observation confirmed by the results of neuroimaging. The practical orientation of the represented scientific report is proved.

Pages

  • 90-94

Year / Issue

Download PDF

References

  1. Mironenko T. V., Khubetova I. V. Opticomyelitis (Devic's disease). Scientific review and own clinical observation // International Neurological Journal. 2015. № 1 (71). С. 141-147.
  2. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders / Wingerchuk D. M., Banwell В., Bennett [et  al.]  // Neurology. 2015; 85(2): 177—189. DOI: https://doi.org/10.1212/WNL.0000000000001729.
  3. Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: Multicenter study of treatment efficacy / M. A. Mealy, D. M. Wingerchuk, J. Palace [et al.] // JAMA Neurol. 2014 Mar; 71(3): 324—30. DOI: https://doi.org/10.1001/jamaneurol.2013.5699.
  4. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica / Jarius S., Aboul-Enein F., Waters P. [et al.] // Brain. 2008; 131: 3072—3080. DOI: https://doi.org/10.1093/brain/awn240.
  5. Damato V. V., Evoli A., Iorio R. Efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis // JAMA Neurol. 2016. Vol. 73. P. 1342—1348. DOI: https://doi.org/10.1001/jamaneurol.2016.1637.
  6. The spectrum of neuromyelitis optica / Wingerchuk D. M., Lennon V. , Lucchinetti C.  F. [et  al.]  // Lancet Neurol. 2007; 6: 805—815. URL: https://www.orpha.net/data/patho/Pro/en/NeuromyelitisOptica-ENenPro10986.pdf.
  7. Matiello M., Weinshenker B. G. Neuromyelitis optica. Chapter 13 Part of Multiple Sclerosis  / Ed.: C.    Lucchinetti, R.  Hohlfeld  // In: Blue Books of  Neurology. 2010. Vol.  35. P.  258—275. DOI: https://doi.org/10.1016/B978-1-4160-6068-0.00013-9.
  8. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica / Cabrera-Yomez J.  , QuevedoSotolongo  Z., González-Quevedo  A. [et  al.] // Mult. Scler. 2007. Vol. 13. P. 186—192. DOI: https://doi.org/10.1177/1352458506070725.
  9. Mariotto S., Ferrari S., Monaco S. Clinical spectrum and IgG subclass analysis of antimyelin oligodendrocyte glycoprotein antibody associated syndromes: a multicenter study // J Neurol. 2017 Dec; 264(12): 2420—30. DOI: https://doi.org/10.1007/s00415-017-8635-4.
  10. Belova A. N., Boyko A. N., Belova E. M. Diagnostic criteria of opticomyelitis-associated disorders // Journal of Neurology and Psychiatry. 2016, no. 2, vol. 2. P. 32-40. DOI: https://doi.org/10.17116/jnevro20161162232-40.
  11. Treatment of Neuromyelitis Optica: Review and Recommendations / Kimbrough D., Fujihara K., Jacob A. [et ]  // Mult Scler Relat Disord. 2012; 1: 180—187. DOI: https://doi.org/10.1016/j.msard.2012.06.002.
  12. Maintenance plasma exchange therapy for steroidrefractory neuromyelitis optica / B.   Khatri, J. Kramer, M. Dukic [et al.] // J. Clin. Apher. 2012. Vol. 27. P. 183—192. DOI: https://doi.org/10.1002/jca.21215.
  13. Pittock S. Y., Zennon V. A., Krecke K. Brain abnormalities in neuromyelitis optica // Arch. Neurol. 2006. Vol. 63. Р. 390—396. DOI: https://doi.org/10.1001/archneur.63.3.390.
  14. Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis / Etemadifar M., Nasr Z., Khalili  [et  al.]  // Mult Scler Int. 2015. Vol.  2015: ID  174720. DOI: https://doi.org/10.1155/2015/174720.
  15. Bakulin I. S., Simaniv T. O., Konovalov R. N., Zakharo-Va M. N. Lesion of area postrema as a cause of indomitable hiccups, nausea and vomiting in diseases of the opticomyelitis spectrum (an observation from practice). Journal of Neurology and Psychiatry. S. S. Korsakov. Special Issues. 2017; 117 (10-2). С. 20-23. DOI: https://doi.org/10.17116/jnevro201711710220-23.

 

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»